Kala Pharmaceuticals, Inc.

( )
KALA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.06%35.230.9%$1166.00m
JNJJohnson & Johnson 1.89%147.960.7%$1011.63m
BMYBristol-Myers Squibb Co. 0.24%57.891.0%$902.16m
MRKMerck & Co., Inc. 1.14%78.230.7%$750.67m
ABBVAbbVie, Inc. 2.31%98.911.9%$715.84m
LLYEli Lilly & Co. 1.12%163.901.1%$625.17m
AZNAstraZeneca Plc 1.37%53.971.2%$295.85m
RPRXRoyalty Pharma Plc -1.23%43.520.1%$177.86m
NVSNovartis AG 1.64%87.490.2%$141.38m
GSKGlaxoSmithKline Plc 1.57%40.700.2%$109.85m
RGENRepligen Corp. 1.90%124.847.1%$109.74m
NVONovo Nordisk A/S 0.52%65.490.1%$82.37m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 4.85%72.920.0%$63.74m
RETAReata Pharmaceuticals, Inc. -2.29%149.523.4%$63.69m
SNYSanofi 2.30%52.110.2%$63.07m

Company Profile

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.